Bupivacaine is a widely used local anesthetic agent.
As an implant, bupivacaine is indicated in adults for placement into the surgical site to produce postsurgical analgesia for up to 24 hours following open inguinal hernia repair.
...
New York Presbyterian Hospital/Columbia University, New York, New York, United States
Children's Memorial Hospital, Chicago, Illinois, United States
Ann & Robert H Lurie Children's Hospital of Chicago, Chicago, Illinois, United States
University of Washington, Seattle, Washington, United States
Newport Hospital, Newport, Rhode Island, United States
Icahn School of Medicine at Mount Sinai, New York, New York, United States
University Hospitals Coventry and Warwickshire, Coventry, Warwickshire, United Kingdom
Alan Edwards Pain Management Unit - Montreal General Hospital, Montreal, Quebec, Canada
Florida Hospital d/b/a Colon & Rectal Surgery Center, Orlando, Florida, United States
University of Arizona College of Medicine, Tucson, Arizona, United States
University of South Florida, Tampa, Florida, United States
Dept. of Plastic and Reconstructive Surgery, Johns Hopkins, Baltimore, Maryland, United States
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.